CI
TEVA icon

Cowen Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Cowen Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,000
Closed -$230K – 295
2016
Q3 		$230K Buy
+5,000
New +$261K 0.01% 208
2015
Q3 		– Sell
-26,000
Closed -$154K – 421
2015
Q2 		$154K Buy
+26,000
New +$1.6M 0.01% 394

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen Inc's TEVA Position: Q4 2016 in Review

Cowen Inc sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 36,165 shares — an estimated $1.44M sold.

Cowen Inc first reported a position in TEVA in Q2 2014 and held it in 8 quarters. The position peaked at $3.03M in Q2 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Cowen Inc reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cowen Inc sold 36,165 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.44M.
  • Cowen Inc first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 8 quarters.
  • Cowen Inc's Teva Pharmaceuticals position peaked at $3.03M in Q2 2015.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.